As PRA Manager for Oncology & Hematology in Finland, you will be the decisive force ensuring Finnish patients gain timely access to Lilly's most innovative treatments—including BTK inhibitors in haematology to next‑generation oncology assets entering the pipeline. You will operate with real autonomy, shaping national access strategies and sitting at the intersection of science, economics and healthcare policy. This is a high‑impact individual contributor role with significant visibility across Lilly's Nordic and global PRA network.
Take the next step and apply for this exciting opportunity
Apply Now